Sphera Funds Management: Funding, Team & Investors | Startup Intros

Loading organizations...

Sphera Funds Management: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Jun 16, 2020	C4 Therapeutics, Inc.	$170.0M Debt / Series B	Todd Kaloudis, Adam Stone	3E Bioventures Capital, Adage Capital Management, Axil Capital, Bain Capital Life Sciences, Commodore Capital, HBM Healthcare Investments, Janus Henderson Investors, Lightchain Capital, Logos Capital, Mizuho Securities Principal Investment, Nextech, RA Capital Management, RTW Investments, T. Rowe Price Associates, Yonjin Capital
Sep 1, 2019	Passage Bio	$110.0M Series B	Access Biotechnology	ARCH Venture Partners, Atlas Venture, Domain Associates, Frazier Healthcare Partners, GE Ventures, InterWest, OrbiMed, Polaris Partners, SV Health Investors, Wildcat Ventures, Boxer Capital, Highline Capital Management, Lilly Asia Ventures, Logos Capital, New Leaf Venture Partners, Versant Ventures, Vivo Capital
Aug 21, 2019	Oncorus	$79.5M Series B	Kevin Raidy, Ellen Hukkelhoven	Arkin Bio Ventures, Astellas Venture Management, Celgene, Deerfield Management, Mitchell Finer, QUAD Investment Management, Shinhan Venture Investment, Surveyor Capital, SV Investment, UTC Investment
Oct 1, 2018	Stoke Therapeutics	$90.0M Series B	RTW Investments	Alexandria Venture Investments, Apple Tree Partners, Bihua Chen, Janus Henderson Investors, Perceptive Advisors, Matthew Hammond, Redmile Group
Sep 29, 2015	Corvus Pharmaceuticals	$75.0M Series B	Rock Springs Capital	Adams Street Partners, BlackRock, Cormorant Asset Management, Cowen Private Investments, Fidelity Management & Research Company, Jennison Associates, Novo Ventures, OrbiMed, Roche, T. Rowe Price Associates